This content is machine translated LDL cholesterol level On the way to the (LDL-C) target Cardiovascular disease ( CVD) is the leading cause of death worldwide. Lowering the level of LDL cholesterol (LDL-C) in the blood reduces the risk of CVD such as heart attacks…
View Post 5 min This content is machine translated Nanobiomaterials Revolutionary approaches to the treatment of cardiac arrhythmias Nanobiomaterials offer a revolutionary opportunity to improve the treatment of cardiac arrhythmias. From targeted drug delivery to tissue regeneration and continuous monitoring, they open up new horizons for personalized medicine.…
View Post 4 min This content is machine translated Cardiogenic shock A complex and life-threatening syndrome Despite considerable progress in cardiovascular medicine and intensive care, cardiogenic shock remains one of the most serious complications of acute heart disease. This life-threatening condition is characterized by inadequate organ…
View Post 4 min This content is machine translated Lipoprotein(a) The higher the Lp(a), the higher the long-term ASCVD risk Numerous studies have shown that elevated Lp(a) levels are associated with the risk of a number of atherosclerotic cardiovascular diseases (ASCVD), including myocardial infarction (MI), stroke and peripheral arterial disease.…
View Post 4 min This content is machine translated Sudden cardiac death after myocardial infarction New perspectives for risk stratification and prevention Sudden cardiac death (SCD) is one of the leading causes of death worldwide and is particularly common in patients who have survived a myocardial infarction (MI). Despite significant advances in…
View Post 3 min This content is machine translated Antiphospholipid syndrome Preferably anticoagulate with VKA or heparin Antiphospholipid syndrome (APS) is an acquired thrombophilia and is associated with a high risk of venous, arterial or microvascular thrombosis. In APS with thrombotic manifestations, lifelong anticoagulation is generally indicated.…
View Post 7 min This content is machine translated Updated guidelines for hypertension Elevated blood pressure as a new category In October, the European Society of Cardiology (ESC) published its 2024 guidelines for the treatment of high blood pressure and hypertension. At the swissESCupdate, Dr. Lucas Lauder from the University…
View Post 4 min This content is machine translated Psycho-cardiology The complex interaction of cardiovascular diseases and mental disorders Psycho-cardiology makes it clear that mental and cardiovascular diseases are closely linked. Integrated treatment that addresses both aspects is crucial to improving the quality of life of those affected and…
View Post 3 min This content is machine translated Heart failure in the light of the latest evidence MRAs offer advantages across the entire EF spectrum At the swissESCupdate, cardiology experts summarized important content from this year’s Annual Meeting of the European Society of Cardiology . In the area of heart failure, studies on the use…
View Post 3 min This content is machine translated Adolescents with type 1 diabetes Metformin can improve subclinical atherosclerosis Neuregulin-4 (Nrg-4) may have anti-inflammatory and anti-atherogenic properties. Egyptian researchers used Nrg-4 together with carotid intima-media thickness as a marker for subclinical atherosclerosis. Their finding: The addition of metformin to…
View Post 5 min This content is machine translated Artificial intelligence Challenges in improving cardiac imaging Cardiovascular disease is the leading cause of death worldwide, and accurate cardiac imaging plays a key role in the diagnosis, treatment and prognosis of these diseases. In recent years, artificial…
